Immediate Impact
31 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Metal–organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances, challenges, and future perspectives
2025 Standout
Works of Jack Junjie Chan being referenced
Emerging systemic therapy options beyond CDK4/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer
2023
Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jack Junjie Chan | 115 | 43 | 11 | 50 | 24 | 178 | |
| Kuikui Jiang | 87 | 46 | 11 | 78 | 29 | 208 | |
| Melita Perić Balja | 114 | 28 | 21 | 44 | 28 | 222 | |
| Olivia D. Lara | 102 | 21 | 22 | 44 | 27 | 177 | |
| Filippo Merloni | 120 | 54 | 5 | 66 | 24 | 208 | |
| Jonathan Macni | 107 | 42 | 10 | 30 | 22 | 185 | |
| Aya El Helali | 91 | 51 | 18 | 78 | 32 | 247 | |
| Ivan Jelas | 128 | 30 | 8 | 35 | 22 | 177 | |
| Hiltje de Graaf | 147 | 53 | 11 | 39 | 18 | 218 | |
| Filippo Crivelli | 151 | 41 | 4 | 58 | 31 | 253 | |
| Maliha Nusrat | 133 | 29 | 5 | 55 | 20 | 204 |
All Works
Login with ORCID to disown or claim papers
Loading papers...